When to test for COVID-19 using real-time reverse transcriptase polymerase chain reaction: a systematic review

Health systems rely on timing data to optimize testing strategies for viral infections like SARS-CoV-2. Prior research has shown that symptom onset varies in relation to test positivity. No prior work had resolved the exact window when RT-PCR is most effective. This uncertainty drove a need to synthesize global data on testing timelines. Researchers have already described symptom patterns in infected individuals. But the link between symptom timing and diagnostic accuracy remained unclear. This gap motivated a systematic review of RT-PCR results across multiple countries. Existing knowledge includes the role of fever and cough in respiratory illness. However, the specific timing of RT-PCR positivity relative to symptoms had not been fully mapped. This paper contributes a global dataset on testing effectiveness over time.

The authors aimed to determine the time interval between symptom onset and first positive RT-PCR result for SARS-CoV-2. They focused on synthesizing global data to inform clinical testing protocols. The study sought to clarify when RT-PCR is most likely to yield accurate results. Researchers wanted to identify symptom patterns that correlate with test positivity. This work addresses a gap in diagnostic timing for viral infections. The goal was to provide evidence-based guidance for health units. They also aimed to describe the most common presenting symptoms. The findings could help refine testing strategies in clinical settings.

The systematic review included databases such as MEDLINE, Embase, and Scopus. Researchers used descriptors like 'SARS-CoV-2' and 'RT-PCR' to identify relevant studies. A total of 90 studies from 31 countries were included in the analysis. The studies varied in design, including prospective and retrospective cohorts. The authors extracted data on symptom onset and test results. They calculated the mean time between symptoms and positive results. Fourteen articles were analyzed for temporal RT-PCR performance. The review focused on synthesizing data on symptom prevalence and testing timelines.

The overall mean time between symptom onset and positive RT-PCR result was 6.72 days. The best performance of RT-PCR was observed on days 22-24 after symptom onset. At this point, 98% of test results were positive. Fever was the most common symptom, affecting 58.68% of patients. Cough and dyspnea affected 46.69% and 29.38% of patients, respectively. The median age of participants was 49.95 years. The study included 6831 patients across various clinical settings. These findings align with current RT-PCR testing practices in some health units.

The study suggests that RT-PCR testing is most effective 22-24 days after symptom onset. The authors propose that fever, cough, and dyspnea are key indicators for testing decisions. These findings may support current clinical practices in some regions. The data indicate that symptom timing influences diagnostic accuracy. The authors suggest that these symptoms can guide RT-PCR testing protocols. The mean time of 6.72 days between symptoms and positivity is a key finding. These results may inform health units about optimal testing windows. The authors emphasize the importance of symptom-based testing decisions.